Premium
Electrocardiographic effects of zatosetron and ondansetron, two 5HT 3 receptor antagonists, in anesthetized dogs
Author(s) -
Williams Patricia D.,
Cohen Marlene L.,
Turk John A.
Publication year - 1991
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.430240309
Subject(s) - ondansetron , 5 ht receptor , pharmacology , propranolol , tropane , medicine , heart rate , antagonist , receptor antagonist , receptor , anesthesia , serotonin , chemistry , blood pressure , stereochemistry , nausea
The pharmacology of 5‐hydroxytryptamine 3 (5HT 3 )‐antagonists is an area under active investigation, and several agents of this class are currently under development for multiple therapeutic indications. Recently, two 5HT 3 receptor antagonists of a tropane derived series, ICS 205 930 and zatosetron, have been shown to alter electrocardiographic properties of heart muscle. A prototypical, but structurally distinct (imidazole) 5HT 3 ‐antagonist, ondansetron, was examined for its comparative cardiovascular activity in anesthetized dogs at intravenous doses of 0.66–5.25 mg/kg. Similar to zatosetron, a significant, dose‐dependent prolongation of the duration of the action potential of the electrocardiogram (Q‐T c interval) occurred following ondansetron exposure, with a maximum increase of 28%. Other cardiovascular parameters (heart rate, mean arterial pressure, pulmonary pressure, cardiac output, peripheral vascular resistance, stroke volume and work index) were essentially unchanged by ondansetron treatment. At equivalent 5HT 3 blocking doses, both ondansetron and zatosetron prolonged the Q‐T c interval in anesthetized dogs similarly. However, for both compounds, the doses required to increase Q‐T c interval were higher than the doses required to demonstrate 5HT 3 receptor blockade. The fact that ondansetron, an imidazole, exhibited electrophysiological effects on cardiac muscle like the 5HT 3 receptor antagonists derived from tropane suggests that the electrocardiographic effects are related to some property shared by 5HT 3 receptor antagonists rather than a property of the tropane structure.